Akers Biosciences Inc logo

AKR - Akers Biosciences Inc Share Price

57.5p 0.0  0.0%

Last Trade - 28/03/19

Sector
Healthcare
Size
Micro Cap
Market Cap £5.12m
Enterprise Value £2.66m
Revenue £1.37m
Position in Universe th / 1834
Bullish
Bearish
Unlock AKR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AKR Revenue Unlock AKR Revenue

Net Income

AKR Net Income Unlock AKR Revenue

Normalised EPS

AKR Normalised EPS Unlock AKR Revenue

PE Ratio Range

AKR PE Ratio Range Unlock AKR Revenue

Dividend Yield Range

AKR Dividend Yield Range Unlock AKR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AKR EPS Forecasts Unlock AKR Revenue
Profile Summary

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious diseases detection, as well as for on and off-the-job alcohol safety initiatives. The Company's primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated March 9, 1989
Public Since July 24, 2008
No. of Shareholders: n/a
No. of Employees: 28
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange London Stock Exchange (Dual Listing)
Shares in Issue 2,513,343
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AKR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AKR
Upcoming Events for AKR
Similar to AKR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.